Decreased B4GALT1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway

Po-Da Chen; Ying-Yu Liao; Yu-Chia Cheng; Hsin-Yi Wu; Yao-Ming Wu; Min-Chuan Huang

doi:10.1038/s41389-023-00494-y

Decreased B4GALT1 promotes hepatocellular carcinoma cell invasiveness by regulating the laminin-integrin pathway

Oncogenesis. 2023 Oct 31;12(1):49. doi: 10.1038/s41389-023-00494-y.

Authors

Po-Da Chen^{1

2

3}, Ying-Yu Liao¹, Yu-Chia Cheng¹, Hsin-Yi Wu⁴, Yao-Ming Wu^{5

6}, Min-Chuan Huang⁷

Affiliations

¹ Graduate Institute of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.
² Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.
³ Department of Surgical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan.
⁴ Instrumentation center, National Taiwan University, Taipei, Taiwan.
⁵ Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan. wyaoming@gmail.com.
⁶ Department of Surgical Oncology, National Taiwan University Cancer Center, Taipei, Taiwan. wyaoming@gmail.com.
⁷ Graduate Institute of Anatomy and Cell Biology, College of Medicine, National Taiwan University, Taipei, Taiwan. mchuang@ntu.edu.tw.

Abstract

Beta1,4-galactosyltransferases (B4GALTs) play a crucial role in several diseases, including cancer. B4GALT1 is highly expressed in the liver, and patients with mutations in B4GALT1 exhibit hepatopathy. However, the role of B4GALT1 in liver cancer remains unclear. Here, we found that B4GALT1 was significantly downregulated in hepatocellular carcinoma (HCC) tissue compared with the adjacent liver tissue, and low B4GALT1 expression was associated with vascular invasion and poor overall survival in patients with HCC. Additionally, silencing or loss of B4GALT1 enhanced HCC cell migration and invasion in vitro and promoted lung metastasis of HCC in NOD/SCID mice. Moreover, B4GALT1 knockdown or knockout increased cell adhesion to laminin, whereas B4GALT1 overexpression decreased the adhesion. Through a mass spectrometry-based approach and Griffonia simplicifolia lectin II (GSL-II) pull-down assays, we identified integrins α6 and β1 as the main protein substrates of B4GALT1 and their N-glycans were modified by B4GALT1. Further, the increased cell migration and invasion induced by B4GALT1 knockdown or knockout were significantly reversed using a blocking antibody against integrin α6 or integrin β1. These results suggest that B4GALT1 downregulation alters N-glycosylation and enhances the laminin-binding activity of integrin α6 and integrin β1 to promote invasiveness of HCC cells. Our findings provide novel insights into the role of B4GALT1 in HCC metastasis and highlight targeting the laminin-integrin axis as a potential therapeutic strategy for HCC with low B4GALT1 expression.